Flexion Therapeutics Inc·4

Jan 4, 5:09 PM ET

KELLEY SCOTT 4

4 · Flexion Therapeutics Inc · Filed Jan 4, 2019

Insider Transaction Report

Form 4
Period: 2019-01-03
KELLEY SCOTT
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2019-01-03$12.36/sh622$7,68815,271 total
Footnotes (1)
  • [F1]Sale of shares of common stock pursuant to Rule 10b5-1 arrangements to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION